Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-05-08
1997-09-16
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 530324, 530345, 530356, 435218, A61K 3843, A61K 3855
Patent
active
056681070
ABSTRACT:
This invention provides a compound comprising:
REFERENCES:
patent: 4485100 (1984-11-01), Hochstrasser et al.
patent: 4496689 (1985-01-01), Mitra
Banda et al., "Regulation of alpha.sub.x proteinase inhibitor function by rabbit alveolar macrophages," J. Clin. Invest. 75:1758-1762 (1985).
Bieth, "Elastases: catalytic and biological properties," Mecham Edition, Regulation of Matrix Accumulation, New York, Academic Press, pp. 217-320 (1986).
Brantly et al., "Molecular basis of alpha-1-antitrypsin deficiency," Amer. J. Med., 84(6A):13-31 (1988).
Bruch et al., "Plasma serine proteinase inhibitors (serpins) exhibit major conformational changes and a large increase in conformational stability upon cleavage at their reactive sites," J. Biol. Chem., 263(32):16626-16630 (1988).
Carrell et al., "Serpins: the superfamily of plasma serine proteinase inhibitors," Proteinase Inhibitors, (Barrett and Salvesan, eds.), Chapter 12, pp. 403-420 (1986).
Carrell, ".alpha..sub.1 -antitrypsin: molecular pathology, leukocytes, and tissue damage," J. Clin. Invest., 78:1427-1431 (1986).
Crystal, "The alpha.sub.1 -antitrypsin gene and its mutations," Chest 91(1):196-208 (1989).
Davidson et al., "Control of elastin synthesis: molecular and cellular aspects," Regulation of Matrix Accumulation, Academic Press, Inc., pp. 177-206 (1986).
Desroches et al., "Proteolytic inactivation of alpha-1-proteinase inhibitor by a neutrophil metalloproteinase," J. Clin. Invest., 81:1646-1650 (1988).
George et al., "A genetically engineered mutant of .alpha..sub.1 -antitrypsin protects connective tissue from neutrophil damage and may be useful in lung disease," The Lancet 1426-1428 (Dec. 22/29, 1984).
Johnson et al., "Structural evidence for methionine at the reactive site of human .alpha.-1-proteinase inhibitor," J. Biol. Chem. 253(20):7142-7144 (1978).
Johnson et al., "Cathepsin L inactivates .alpha..sub.1 -proteinase inhibitor by cleavage in the reactive site region," J. Biol. Chem., 261(31):14748-14751 (1986).
Knauper et al., "Inactivation of human plasma .alpha..sub.1 -proteinase inhibitor by human PMN leucocyte collagenase," FEBS Letters, 263(2):355-357 (1990).
Kress et al., "Characterization of the inactive fragment resulting from limited proteolysis of human .alpha..sub.1 -proteinase inhibitor by Crotalus adamanteus proteinase II," J. Biol. Chem., 254(12):5317-5320 (1979).
Kushner, "The acute phase response: an overview," Meth. Enzymol., 163:373-383 (1988).
Laurell et al., "Protease inhibitors in plasma," The Plasma Proteins (Putnam, ed.), vol. 1, pp. 229-264 (1975).
Lo et al., "The interaction of .alpha.-1-antitrypsin with soluble and sepharose-bound elastase," Biochimica et Biophys. Acta., 453:344-356 (1976).
Long et al., "Complete sequence of the cDNA for human .alpha..sub.1 -antitrypsin and the gene for the S variant," Biochem. 23:4828-4837 (1984).
Mast et al., "Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of .alpha..sub.1 -proteinase inhibitor, .alpha..sub.1 -antichymotrypsin, antithrombin III, .alpha..sub.2 -antiplasmin, angiotensinogen, and ovalbumin," Biochem. 30:1723-1730 (1991).
Michaelis et al., "Human neutrophil collagenase cleaves .alpha..sub.1 -antitrypsin," Biochem. J. 270:809-814 (1990).
Morihara et al., "Purification of human plasma .alpha..sub.1 -proteinase inhibitor and its inactivation by Pseudomonas aeruginosa elastase," J. Biochem., 95:795-804 (1984).
Niemann et al., "Isolation and serine protease inhibitory activity of the 44-residue, C-terminal fragment of .alpha..sub.1 -antitrypsin from human placenta," Matrix 12:233-241 (1992).
Niemann et al., "Binding of SPAAT, the 44-residue C-terminal peptide of .alpha..sub.1 -antitrypsin (AAT), to proteins of the extracellular matrix (ECM)," Amer. Soc. for Cell Biol., Abstract (1995).
Patston et al., "Serpinds are suicide substrates: implications for the regulation of proteolytic pathways," Sem. Throm. Hemost. 20(4):410-416 (1994).
Pei et al., "Hydrolytic inactivation of a breast carcinoma cell-derived setpin by human stromelysin-3," J. Biol. Chem., 269(41):25849-25855 (1994).
Perimutter et al., "Identification of a serpin-enzyme complex receptor on human hepatoma cells and human menocytes," Proc. Natl. Acad. Sci. USA, 87:3753-3757 (1990).
Potempa et al., "The inactivation of human plasma .alpha..sub.1 -proteinase inhibitor by proteinases from Staphylococcus aureus," J. Biol. Chem.261:14330-14334 (1986).
Rinehart et al., "Human .alpha..sub.1 -proteinase inhibitor binds to extracellular matrix In Vitro," Am. J. Respir. Cell Mol. Biol., 9:666-679 (1993).
Satoh et al., "The dual nature of the reaction between porcine elastase and human plasma .alpha..sub.1 -proteinase inhibitor," Biochem. and Biophys. Res. Comm., 86(1):130-137 (1979).
Schreiber, "Synthesis, processing, and secretion of plasma proteins by the liver and other organs and their regulation,"0 The Plasma Proteins (Academic Press Inc.), vol. 5, pp. 292-363 (1987).
Travis et al., "Human plasma proteinase inhibitors," Ann. Rev. Biochem. 52:655-709 (1983).
Virca et al., "Inactivation of human plasma .alpha..sub.1 -proteinase inhibitor by a metalloproteinase from Serratia marcescens," Biochem. Biophys. Acta. 704:267-271 (1982).
Weiss et al., "Neutrophils degrade subendothelial matrices in the persence of alpha-1-proteinase inhibitor," J. Clin. Invest., 73:1297-1303 (1984).
Adler Benjamin Aaron
Schain Howard E.
The UAB Research Foundation
LandOfFree
Compositions and methods for inhibiting elastase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for inhibiting elastase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for inhibiting elastase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-218168